• Integrative Mental Health Conference - All Presentations

    Original Date: December 4-5, 2021

    This discounted package includes all of the individual presentations from the conference, which are listed below.

    12.5 CEUs (including 6.25 general, 3.75 ethics, and 2.5 pharmacy) approved by OBNM

  • Mental Health and College Students

    Presenter: Rachel Neuendorf, ND
    Original Date: December 4, 2021

    Mental health concerns have become increasingly prevalent on college campuses with up to 40% of students experiencing a significant mental health issue. This presentation will discuss the most common mental health concerns in college students including depression, suicidal ideation, anxiety, ADHD, substance abuse and eating disorders. An overview of the brain development of teenagers and young adults will be given to help understand why some behaviors and mental health conditions are more common in this population. I will go over options for screening and evaluating college students as well as special considerations for treating young adults with mental health concerns. We will also explore the various ways the COVID-19 pandemic has impacted mental health and how this population connects and seeks help. Finally, I will present on some pertinent topics for consideration including LGBTQ+, race/ethnicity, and social media.

    0.75 general, 0.5 ethics, 0.25 pharm CEUs approved by OBNM

  • Standards of Care in Delivering Telemental Health Services by Videoconferencing

    Presenter: Roy Huggins, LPC, NCC
    Original Date: December 4, 2021

    Consent Elements/ Assessing appropriateness.
    Medium, Ethical lenses, Varied considerations in appropriateness
    Informed consent and connecting the patient to the process of self care involved
    Special considerations of the therapy dyad
    Sample form
    Risk benefit analysis: Sample Risk Analysis form – need to do and when to do. Some states require.
    Preassessment and some insurances
    Safety planning and practices
    Equipment-Hardware-Software review
    HIPAA and COVID variations
    Physiology of a session and connection to standards
    Gaze, postures, observing client, distance from screen, eye contact
    Online disinhibition effect
    Telehealth and coverage/payment parity concerns.

    2.0 ethics CEUs approved by OBNM

  • From Trauma and Crisis to Transformation and Advocacy: The Journey of an Integrative Psychiatrist on the Frontlines

    Presenter: Noshene Ranjbar, MD
    Original Date: December 4, 2021

    Dr. Ranjbar’s biography as relevant to
    Culturally sensitive trauma informed care
    Medical training and burn out (caring for the care giver)
    Contribution to integrated psychiatry, defining integrated psychiatry
    Indigenous medical practices and connections to alternative medicine
    Immigrant journey and practice
    Autoimmunity and family health concerns as relevant to practice and practitioner self care
    Ethical lenses
    Varied considerations in appropriateness, dignity and the cycle of care between practitioner and community of practice
    Special considerations of community and cultural heritage

    Specific study of work with indigenous populations, immigrants, border-detainees, refugees
    Work with training medical students
    Alternative medicine and biomedicine light case study with culturally sensitive focus
    Trauma informed care – culturally sensitive informed care – details.
    Example of alternative self care that also is trauma informed care that is applicable to varied cultural applications.

    1.5 general CEUs approved by OBNM

  • Treating a Situational Depression in a Global Pandemic

    Presenter: Molly Rodden, MSN, FNP=C, PMHNP-C
    Original Date: December 4, 2021

    Presentation Overview or Summary Outline
    1) Overview of Adjustment Disorder per DSM V criteria
    2) Overview of Major Depressive Disorder per DSM V criteria
    3) Discussion of differences and similarities including time frame
    4) Discussion of ethical considerations when treating Depression in what may be a time limited condition
    5) Discussion of "big picture thinking" in regards to treatment of what may be a time limited condition
    6) Picking agents and discussing options with the patient
    7) Considerations for Agent: ease of titration and discontinuation, potential/ probability of SE,
    8) Consideration for treatment: clients perception, likelihood of remission, history of previous illness, overall impact (to multiple domains) to ADL/ quality of life/ cognitive function
    9) Answer questions.

    This seminar will discuss the pharmaceuticals:
    SSRI - Zoloft, Lexapro, Celexa, Prozac SNRI- Effexor, Wellbutrin, Cymbalta Mood Stabilizer- Lamictal

    0.75 general, 0.5 pharm, 0.25 ethics CEUs approved by OBNM

  • Weaning of Psychotropic Medications, with a Focus on Updated Information Around Depression, Insomnia, and Anxiety

    Presenter: Philip Rouchotas, MS, ND
    Original Date: December 5, 2021

    Depression, anxiety, and insomnia had reached epidemic proportions prior to the pandemic, and ongoing pandemic restrictions have added to the burden of these common mental health concerns. A growing body of literature is challenging conventional strategies of managing these concerns, including a plethora of journal publications and books written by the who’s who of academia openly criticizing pharmacotherapy for these concerns. After showcasing these highlights and the brilliant scientists trying to raise awareness, the talk will briefly review a comprehensive integrative approach for management of depression, anxiety, and insomnia. The focus of the talk will be to review recent advances of guidelines for weaning prescription psychotropic medications (focus on SSRI class of antidepressants as well as benzodiazepines). Appropriate timing and magnitude of prescription dose reduction, appropriate supportive integrative strategies during the weaning process, and ensuring attendees can differentiate challenges that arise for weaning antidepressants relative to benzodiazepines will comprise the focus of the lecture.
    Specific medications will be reviewed, yet I wish to stress that they are reviewed in context of “drug class.” While discussing SSRI’s, a handful of specific SSRI’s will be highlighted as examples (I usually cover Prozac and Zoloft). Due to unique challenges facing two, I always specifically review Effexor and Pristiq. Likewise, benzodiazepines are reviewed as a class, yet in so doing, one or two are mentioned specifically, usually lorazepam and clonazepam.

    1.0 pharmacy, 0.25 ethics, and 0.25 general CEUs approved by OBNM

  • Why Everything You Know About Addiction is Wrong - A Guide to Addiction Ideologies, Medications, and Herbs

    Presenter: Lydia Bartholow, DNP, PMHNP, CARN-AP
    Original Date: December 5, 2021

    This brief workshop will take the participant on a quick journey on most things related to addiction and substance use disorders. We will review how trauma makes us neurobiologically vulnerable to developing use disorders, as well as why a trauma informed and harm reduction approach is necessary within the world of addiction. We will review the role of stigma in the treatment of addiction, and discuss how and why stigma informs public health policy as well as your clinical practice. We will wrap up with a review of both allopathic medications used in the treatment of use disorders (e.g. buprenorphine. methadone or naltrexone) and common herbs utilized for harm reduction and addiction intervention.

    0.5 general, 0.75 ethics, and 0.25 pharmacy CEUs approved by OBNM

  • The Mechanisms of Actions of Psilocybin

    Presenter: Erica Zelfand, ND
    Original Date: December 5, 2021

    In this talk we will examine the pharmacology of psilocybin and also look at “classic psychedelics,” namely psilocybin (the active constituent in “magic mushrooms”) and LSD-25 (also known as “acid”). The effects of these medicines on neurological function, chemistry, and signaling will also be reviewed, and the concepts of the default mode network (DMN), brain entropy, and child consciousness will be introduced. Finaly slides: We will also take a closer look at the role of mystical experiences, and what spirituality has to do with psychological and physiological healing.
    Topics of special focus are
    Ergolines 5:
    oLSD and analogues
    oErgoline - Used clinically for vasoconstriction
    -Tryptamines 6
    specifically covering in depth-Psilocybin/psilocin,
    o-DMT (ayahuasca),
    - Phenethylamines
    -Antidepressants especially Bupropion
    Special notes on 5-HT2A and serotonin and lit on LSD.

    1.0 general and 0.5 pharmacy CEUs approved by OBNM

  • Don't Let the Blues Bring You Down: Using Posture and Movement to Diagnose and Treat Anxiety and Depression

    Presenter: Elizabeth Wallace, ND, LAc
    Original Date: December 5, 2021

    Review basics of mental health for an ‘inflamed’ brain,
    Consider neurological habits, look especially at those that are involved in autoimmune and stress responses,
    Connect especially to neurobiological path way. Look especially at data relevant to fear, stress & PTSD
    Look at perspective relevant to structural integration, pelvic floor, posture and special dynamics,
    Case studies using these and their tools to gain perspective on how to understand, diagnose and intervene in mental health especially as it connects to anxiety and depression,
    Receive hands-on techniques to 'diagnose' and treat both yourself and use with others.

    1.5 general CEUs approved by OBNM

Privacy Policy